rosiglitazone has been researched along with Seizures in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Amini, A; Ayatollahi, AA; Chen, S; Koohsar, F; Li, J; Wang, F; Zeyghami, MA; Zhang, J | 1 |
| Boes, K; Licko, T; Ongerth, T; Potschka, H; Russmann, V; Salvamoser, JD; Siegl, C | 1 |
| Cheng, SJ; Hung, WC; Lee, WT; Min, MY; Wong, SB | 1 |
| El-Agamy, DS; Said, SA | 1 |
| Deng, Y; Huang, Y; Li, R; Li, Y; Sun, H; Yang, J; Yu, X; Zhao, G | 1 |
6 other study(ies) available for rosiglitazone and Seizures
| Article | Year |
|---|---|
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Effect of Rosiglitazone, the Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, on Apoptosis, Inflammatory Cytokines and Oxidative Stress in pentylenetetrazole-Induced Seizures in Kindled Mice.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Cytokines; Interleukin-10; Interleukin-6; Kindling, Neurologic; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Pentylenetetrazole; PPAR gamma; PPAR-gamma Agonists; Pyroptosis; Rosiglitazone; Seizures; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
Expression regulation and targeting of the peroxisome proliferator-activated receptor γ following electrically-induced status epilepticus.
Topics: Animals; Behavior, Animal; Electric Stimulation; Female; Gene Expression Regulation; Hippocampus; Maze Learning; Neurons; Parietal Lobe; Piriform Cortex; PPAR gamma; Rats, Sprague-Dawley; Rosiglitazone; Seizures; Spatial Learning; Status Epilepticus; Thiazolidinediones | 2015 |
Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy.
Topics: Action Potentials; Anilides; Animals; CA1 Region, Hippocampal; Culture Media; Epilepsy, Temporal Lobe; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Glutamic Acid; Magnesium; Microtomy; Models, Biological; Neurons; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Seizures; Synaptic Transmission; Thiazolidinediones; Tissue Culture Techniques | 2015 |
Prevention of sodium valproate-induced hepatotoxicity by curcumin, rosiglitazone and N-acetylcysteine in rats.
Topics: Acetylcysteine; Animals; Anticonvulsants; Body Weight; Chemical and Drug Induced Liver Injury; Convulsants; Curcumin; Eating; Fatty Liver; Free Radical Scavengers; Hypoglycemic Agents; Liver; Liver Function Tests; Male; Mice; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Rosiglitazone; Seizures; Thiazolidinediones; Valproic Acid | 2010 |
Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
Topics: Animals; Benzamides; Blotting, Western; Brain Injuries; CD40 Antigens; Central Nervous System Diseases; Enzyme-Linked Immunosorbent Assay; Epilepsy; Hippocampus; Immunohistochemistry; Inflammation; Lithium Compounds; Male; Pilocarpine; PPAR gamma; Pyridines; Rats; Rats, Sprague-Dawley; Rosiglitazone; Seizures; Status Epilepticus; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2008 |